Difficulty: Medium
Average Score: 85%
Practice
Which of the following drugs may cause reversible gynecomastia?
Correct answer
C
Rationale
In the context of Safety Pharmacology Across the Lifespan, understanding the potential adverse effects of drugs is crucial for healthcare professionals. In this case, the correct answer is C) Cimetidine, which may cause reversible gynecomastia.
Cimetidine is a histamine H2-receptor antagonist, and one of its known side effects is the development of gynecomastia in males. This is due to its anti-androgenic effects which can disrupt the normal hormonal balance, leading to breast tissue enlargement.
Regarding the other options:
A) Omeprazole is a proton pump inhibitor used to reduce stomach acid production, and it is not typically associated with gynecomastia.
B) Pirenzepine is an M1 muscarinic receptor antagonist primarily used for peptic ulcers and is not known to cause gynecomastia.
D) Sucralfate is a medication used to treat and prevent ulcers in the intestines, and it is not linked to gynecomastia.
Educationally, this question highlights the importance of recognizing potential adverse effects of medications, emphasizing the need for healthcare providers to be vigilant in monitoring and assessing patients for such outcomes, especially in vulnerable populations such as the elderly or children where drug effects can differ. Understanding these nuances can aid in safe prescribing practices and patient management.
Cimetidine is a histamine H2-receptor antagonist, and one of its known side effects is the development of gynecomastia in males. This is due to its anti-androgenic effects which can disrupt the normal hormonal balance, leading to breast tissue enlargement.
Regarding the other options:
A) Omeprazole is a proton pump inhibitor used to reduce stomach acid production, and it is not typically associated with gynecomastia.
B) Pirenzepine is an M1 muscarinic receptor antagonist primarily used for peptic ulcers and is not known to cause gynecomastia.
D) Sucralfate is a medication used to treat and prevent ulcers in the intestines, and it is not linked to gynecomastia.
Educationally, this question highlights the importance of recognizing potential adverse effects of medications, emphasizing the need for healthcare providers to be vigilant in monitoring and assessing patients for such outcomes, especially in vulnerable populations such as the elderly or children where drug effects can differ. Understanding these nuances can aid in safe prescribing practices and patient management.